col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


100 Ergebisse       Seite 1

 [1] 
Oxford University Press: American Journal of Epidemiology
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2025―Apr―30 Comparative evaluation of methodologies for estimating the effectiveness of non-pharmaceutical interventions in the context of COVID-19: a simulation study Iris Ganser, Juliette Paireau, David L Buckeridge, Simon Cauchemez, Rodolphe Thiébaut, Mélanie Prague
2 [GO] 2024―Sep―25 Impact of COVID-19 on Precocious Puberty: A Meta-Analysis and Its Relevance to Philippine Pediatric Health John Patrick Toledo
3 [GO] 2024―Sep―18 COVID-19 Mortality in Kentucky by Age and Race: Simpson’s Paradox Steven Auche, Claire Holiday, Kathleen Winter, Douglas Thoroughman, Kevin B Spicer
4 [GO] 2024―Sep―10 Refining Estimation of the Instantaneous Reproduction Number During Early Pandemic Stages: Addressing Case-Reporting Variability and Serial Interval Uncertainty Gary Hettinger, David Rubin, Jing Huang
5 [GO] 2024―Sep―02 Reduced Risk of SARS-CoV-2 Infection Among Household Contacts with Recent Vaccination and Past COVID-19 Infection: Results from Two Multi-Site Case-Ascertained Household Transmission Studies Melissa A Rolfes, H Keipp Talbot, Kerry Grace Morrissey, Melissa S Stockwell, Yvonne Maldonado, Huong Q McLean, et al. (+38)
6 [GO] 2024―Sep―02 U.S. County-level Food Insecurity and COVID-19 Mortality: A Bayesian Spatial Analysis with R-INLA Christian A Maino Vieytes, Mauricio Campos, Sara L McLafferty, May A Beydoun, Francesca Gany, Anna E Arthur, Rebecca L Smith
7 [GO] 2024―Aug―29 Tracking vaccine effectiveness in an evolving pandemic, countering misleading hot takes and epidemiological fallacies Jeffrey S Morris
8 [GO] 2024―Aug―27 Applying a Bayesian Spatiotemporal Model to Examine Excess County-Level Cardiovascular Disease Death Rates During the COVID-19 Pandemic Adam S Vaughan, Harrison Quick, Kara B Beck, Rebecca C Woodruff, David DeLara, Michele Casper
9 [GO] 2024―Aug―22 Risk of COVID-19 Reinfection and Vaccine Breakthrough Infection, Madera County, California, 2021 Minhphuong Nguyen, Eric Paul, Paul K Mills, Simon Paul
10 [GO] 2024―Aug―09 The mediating role of SARS-CoV-2 variants between income and hospitalisation due to COVID-19: A period-based mediation analysis Sean P Harrigan, Chad D Fibke, Héctor A Velásquez García, Sunny Mak, James Wilton, Natalie Prystajecky, et al. (+7)
11 [GO] 2024―Aug―08 Generalized anxiety disorder in low-resourced adults: a nationally representative, longitudinal cohort study across the COVID-19 pandemic Catherine K Ettman, Salma M Abdalla, Ruochen Wang, Samuel B Rosenberg, Sandro Galea
12 [GO] 2024―Jul―17 Insights into COVID-19 epidemiology and control from temporal changes in serial interval distributions in Hong Kong Sheikh Taslim Ali, Dongxuan Chen, Yiu-Chung Lau, Wey Wen Lim, Amy Yeung, Dillon C Adam, et al. (+11)
13 [GO] 2024―Jul―16 Barriers to initial COVID-19 booster among U.S. adults who completed a primary vaccine series in the CHASING COVID cohort, September 2021 - October 2022 Madhura S Rane, Yanhan Shen, Mc Kaylee Robertson, Kate Penrose, Avantika Srivastava, Laura Puzniak, et al. (+9)
14 [GO] 2024―Jul―05 Assessing the Quality of Cause-of-Death Reporting Before and During the COVID-19 Pandemic Shu-Yu Tai, Ichiro Kawachi, Tsung-Hsueh Lu
15 [GO] 2024―Jul―04 A causal machine-learning framework for studying policy impact on air pollution: A case-study in COVID-19 lockdowns Claire Heffernan, Kirsten Koehler, Misti Levy Zamora, Colby Buehler, Drew R Gentner, Roger D Peng, Abhirup Datta
16 [GO] 2024―Jul―04 Applying two approaches to detect unmeasured confounding due to time-varying variables in a self-controlled risk interval design evaluating COVID-19 vaccine safety signals, using myocarditis as a case example Sophie H Bots, Svetlana Belitser, Rolf H H Groenwold, Carlos E Durán, Judit Riera-Arnau, Anna Schultze, et al. (+17)
17 [GO] 2024―Jul―03 Death on the permafrost: Revisiting the 1918-20 influenza pandemic in Alaska using death certificates Lisa Sattenspiel, Svenn-Erik Mamelund, Sushma Dahal, Amanda Wissler, Gerardo Chowell, Emma Tinker-Fortel
18 [GO] 2024―Jun―21 A Propensity Score Approach and a Partitioned Approach for the Self-Controlled Case Series Design to Evaluate Safety of a 2-dose Vaccine Series: Application to myocarditis/pericarditis following mRNA COVID-19 vaccination Stanley Xu, Lina S Sy, Bing Han, Vennis Hong, Katia J Bruxvoort, Bruno Lewin, et al. (+2)
19 [GO] 2024―Jun―18 Prior infections and effectiveness of SARS-CoV-2 vaccine in test-negative studies: A systematic review and meta-analysis Tim K Tsang, Sheena G Sullivan, Xiaotong Huang, Can Wang, Yifan Wang, Joshua Nealon, et al. (+3)
20 [GO] 2024―Jun―15 The pandemic preterm paradox: A test of competing explanations Ralph A Catalano, Tim A Bruckner, Alison Gemmill, Claire E Margerison
21 [GO] 2024―Jun―14 SARS-CoV-2 incidence, seroprevalence, and antibody dynamics in a rural, population-based cohort: March 2020 - July 2022 Joshua G Petrie, David Pattinson, Jennifer P King, Gabriele Neumann, Lizheng Guan, Peter Jester, et al. (+6)
22 [GO] 2024―Mai―29 Detecting changes in population trends in infection surveillance using community SARS-CoV-2 prevalence as an exemplar Emma Pritchard, Karina-Doris Vihta, David W Eyre, Susan Hopkins, Tim E A Peto, Philippa C Matthews, et al. (+7)
23 [GO] 2024―Mai―22 The role and limitations of electronic medical records versus patient interviews for determining symptoms, underlying comorbidities, and medication usage for patients with COVID-19 Raymond A Soto, Grace M Vahey, Kristen E Marshall, Emily McDonald, Rachel Herlihy, Helen M Chun, et al. (+7)
24 [GO] 2024―Mai―22 Human Epidemiology and RespOnse to SARS-CoV-2 (HEROS): Objectives, Design and Enrollment Results of a 12-City Remote Observational Surveillance Study of Households with Children using Direct-to-Participant Methods Patricia C Fulkerson, Stephanie J Lussier, Casper G Bendixsen, Sharon M Castina, Tebeb Gebretsadik, Jessica S Marlin, et al. (+32)
25 [GO] 2024―Mai―16 Current use of estrogen-containing oral contraceptives or hormone therapy and risk of COVID-19 infection and hospitalization: a population-based cohort study Laura B Harrington, J David Powers, Elizabeth A Bayliss, Stephen P Fortmann, Susan M Shortreed, Rod L Walker, et al. (+7)
26 [GO] 2024―Mai―14 COVID-19 Pandemic Exacerbated Socioeconomic Disparities in Motor Vehicle Traffic Fatalities Brian C Tefft, Rebecca Steinbach
27 [GO] 2024―Mai―14 Correction to “Postacute symptoms 4 months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study”
28 [GO] 2024―Mrz―18 Avoidance of care: how health-care affordability influenced COVID-19 disease severity and outcomes Chinyere J Okpara, Jasmin Divers, Megan Winner
29 [GO] 2024―Mrz―18 Re: “Postacute symptoms 4 months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study” Bronner P Gonçalves
30 [GO] 2024―Feb―29 Missing data and missed infections: Investigating racial and ethnic disparities in SARS-CoV-2 testing and infection rates in Holyoke, Massachusetts Sara M Sauer, Isabel R Fulcher, Wilfredo R Matias, Ryan Paxton, Ahmed Elnaiem, Sean Gonsalves, et al. (+4)
31 [GO] 2024―Feb―20 Understanding racial/ethnic disparities in COVID-19 mortality using a novel metric: COVID excess mortality percentage Andy Ye Yuan, Vladimir Atanasov, Natalia Barreto, Lorenzo Franchi, Jeff Whittle, Benjamin Weston, et al. (+3)
32 [GO] 2023―Dez―23 Life Expectancy among Native Americans during the COVID-19 Pandemic: Estimates, Uncertainty and Obstacles Noreen Goldman, Sung S Park, Hiram Beltrán-Sánchez
33 [GO] 2023―Dez―12 Revisiting a risk benefit analysis of mRNA COVID-19 vaccines during the omicron era Raphael Lataster
34 [GO] 2023―Dez―07 RE: “Risk and benefit OF mRNA COVID-19 vaccines for the omicron variant by age, sex, and presence of comorbidity: a quality-adjusted life years analysis” Makoto Shiraishi, Masakazu Kurita, Kou Fujisawa, Mutsumi Okazaki
35 [GO] 2023―Nov―15 The Landscape of NIAID-funded Observational COVID-19 Cohort Studies Reed S Shabman, Mason Booth, Michael Cooper, Marciela M DeGrace, Patricia C Fulkerson, Teresa Hauguel, et al. (+10)
36 [GO] 2023―Nov―15 Post-acute symptoms 4 months after SARS-CoV-2 infection during the Omicron period: a nationwide Danish questionnaire study Lampros Spiliopoulos, Anna Irene Vedel Sørensen, Peter Bager, Nete Munk Nielsen, Jørgen Vinsløv Hansen, Anders Koch, et al. (+4)
37 [GO] 2023―Nov―15 Anti-COVID-19 measures and lifestyle changes during theCOVID-19 pandemic and sleep patterns in the Netherlands: a longitudinal study Nekane Sandoval-Diez, Lidwien A M Smit, Jolanda M A Boer, Myrna M T de Rooij, Gerard H Koppelman, Warner van Kersen, et al. (+4)
38 [GO] 2023―Nov―08 Double-Negative Results Matter: A Reevaluation of Sensitivities for Detecting SARS-CoV-2 Infection Using Saliva Versus Nasopharyngeal Swabs Zheng Wang, Yu-Lun Liu, Yong Chen, Lianne Siegel, Joseph C Cappelleri, Haitao Chu
39 [GO] 2023―Okt―12 Clinical Features and Outcomes of Hospitalized Adult Patients with Breakthrough COVID-19 Infections: A Propensity Score-Matched Observational Study Jianli Niu, Shenae Samuels, Candice Sareli, Daniel Mayer, Alvaro Visbal, Aharon E Sareli
40 [GO] 2023―Sep―16 Demographic and Geographic Characterization of Excess Mortality During the COVID-19 Pandemic in Baltimore City, MD, March 2020 - March 2021 Kyle T Aune, Kyra H Grantz, Neia Prata Menezes, Katherine O Robsky, Emily S Gurley, Melissa A Marx, Darcy F Phelan-Emrick
41 [GO] 2023―Sep―01 Life Expectancy Changes During the COVID-19 Pandemic, 2019-2021: Highly Racialized Deaths in Young and Middle Adulthood Distinguish the United States Among High-Income Countries Ryan K Masters, Laudan Y Aron, Steven H Woolf
42 [GO] 2023―Sep―01 Challenges in Estimating Effectiveness of 2 Doses of COVID-19 Vaccines Beyond 6 Months in England Elsie M F Horne, William J Hulme, Ruth H Keogh, Tom M Palmer, Elizabeth J Williamson, Edward P K Parker, et al. (+12)
43 [GO] 2023―Aug―22 Risk factors for community and intra-household transmission of SARS-Cov-2: a modelling study in the French national population-based EpiCov cohort Sophie Novelli, Lulla Opatowski, Carmelite Manto, Delphine Rahib, Xavier de Lamballerie, Josiane Warszawski, et al. (+2)
44 [GO] 2023―Aug―08 Population Attributable Fraction of Non-Vaccination of COVID-19 Due to Vaccine Hesitancy, United States, 2021 Kimberly H Nguyen, Ruitong Zhao, Siyu Chen, Akhil K Vaish, Robert A Bednarczyk, Lavanya Vasudevan
45 [GO] 2023―Mai―31 Impact of allocation concealment and blinding in trials addressing treatments for COVID-19: A methods study Dena Zeraatkar, Tyler Pitre, Juan Pablo Diaz-Martinez, Derek Chu, Bram Rochwerg, Francois Lamontagne, et al. (+4)
46 [GO] 2023―Mai―24 The Evolution of Excess Deaths in the United States During the First Two Years of the COVID-19 Pandemic Christopher J Ruhm
47 [GO] 2023―Mai―16 Use of community SARS-CoV2 case counts and instantaneous reproductive number to predict short-term COVID-19 hospital admission volumes Michael I Oppenheim, Juan Rada, Abraham Saraya, Kevin R Bock, John D’Angelo, Bruce Farber
48 [GO] 2023―Apr―29 SARS-CoV-2 Serology Across Scales: A Framework for Unbiased Estimation of Cumulative Incidence Incorporating Antibody Kinetics and Epidemic Recency Saki Takahashi, Michael J Peluso, Jill Hakim, Keirstinne Turcios, Owen Janson, Isobel Routledge, et al. (+9)
49 [GO] 2023―Apr―21 A mixture model to estimate SARS-CoV-2 seroprevalence in Chennai, India Matt D T Hitchings, Eshan U Patel, Rifa Khan, Aylur K Srikrishnan, Mark Anderson, K S Kumar, et al. (+7)
50 [GO] 2023―Apr―19 Long COVID Incidence in a Large US Ambulatory Electronic Health Record System Robert Sedgley, Jessamine Winer-Jones, Machaon Bonafede
51 [GO] 2023―Apr―13 Behavioral and personal characteristics associated with risk of SARS-CoV-2 infection in a Spanish university cohort Fares Amer, Mario Gil-Conesa, Silvia Carlos, Arturo H Ariño, Francisco Carmona-Torre, Miguel A Martínez-González, Alejandro Fernandez-Montero
52 [GO] 2023―Apr―07 Standardized cumulative metrics of excess mortality to monitor health system resilience throughout COVID-19 and other respiratory virus resurgences Gkikas Magiorkinis
53 [GO] 2023―Mrz―24 Comment on Risk and benefit of mRNA COVID-19 vaccines for Omicron variant Amnuay Kleebayoon, Viroj Wiwanitkit
54 [GO] 2023―Mrz―17 COVID-19 Vaccine Safety Surveillance in Early Pregnancy in the United States: Design Factors Affecting the Association Between Vaccine and Spontaneous Abortion Gabriela Vazquez-Benitez, Jacob L Haapala, Heather S Lipkind, Malini B DeSilva, Jingyi Zhu, Matthew F Daley, et al. (+12)
55 [GO] 2023―Mrz―15 Risk and benefit of mRNA COVID-19 vaccines for Omicron variant by age, sex and presence of comorbidity: a quality-adjusted life years analysis Taito Kitano, David A Thompson, Lilly Engineer, Matthew Dudley, Daniel A Salmon
56 [GO] 2023―Mrz―08 Response to “Commentary: Does Covid-19 vaccination disturb menstrual cycling?” by Clarice Weinberg, PhD Emily R Boniface, Alison B Edelman, Blair G Darney
57 [GO] 2023―Mrz―08 Retrospective, Observational Studies for Estimating Vaccine Effects on the Secondary Attack Rate of SARS-CoV-2 Marlena S Bannick, Fei Gao, Elizabeth R Brown, Holly E Janes
58 [GO] 2023―Feb―24 Modern epidemiology confronts COVID-19: reflections from psychiatric epidemiology Gonzalo Martínez-Alés, Katherine Keyes
59 [GO] 2023―Feb―17 Design and Implementation of the All of Us Research Program COVID-19 Participant Experience (COPE) Survey Claire E Schulkey, Tamara R Litwin, Genevieve Ellsworth, Heather Sansbury, Brian K Ahmedani, Karmel W Choi, et al. (+20)
60 [GO] 2023―Feb―17 Commentary: Does Covid-19 vaccination disturb menstrual cycling? Clarice Weinberg
61 [GO] 2023―Jan―27 Waning of two-dose BNT162b2 and mRNA-1273 vaccine effectiveness against symptomatic SARS-CoV-2 infection is robust to depletion-of-susceptibles bias Kristin L Andrejko, Jake M Pry, Jennifer F Myers, Megha Mehrotra, Katherine Lamba, Esther Lim, et al. (+7)
62 [GO] 2023―Jan―27 Undiagnosed and Undertreated: The Suffocating Consequences of Racially-Biased Medical Devices During the COVID-19 Pandemic Marie V Plaisime
63 [GO] 2023―Jan―12 Everyone Wins: Vaccine Lotteries Can Cost-Effectively Increase COVID-19 Booster Vaccination Rates Zoë M McLaren
64 [GO] 2023―Jan―10 A demonstration of Modified Treatment Policies to evaluate shifts in mobility and COVID-19 case rates in U.S. counties Joshua R Nugent, Laura B Balzer
65 [GO] 2023―Jan―05 Some Social Epidemiologic Lessons from the COVID-19 Pandemic Alina S Schnake-Mahl, Usama Bilal
66 [GO] 2022―Nov―24 Current Challenges With the Use of Test-Negative Designs for Modeling COVID-19 Vaccination and Outcomes Xu Shi, Kendrick Qijun Li, Bhramar Mukherjee
67 [GO] 2022―Nov―02 Performance of Existing and Novel Symptom- and Antigen Testing-Based COVID-19 Case Definitions in a Community Setting Scott Lee, Olivia Almendares, Jessica Prince-Guerra, Mark Anderson, Charles M Heilig, Jacqueline E Tate, Hannah L Kirking
68 [GO] 2022―Okt―10 Optimizing SARS-CoV-2 Pooled Testing Strategies Through Differentiated Pooling for Distinct Groups Lindsey M Filiatreau, Paul N Zivich, Jessie K Edwards, Grace E Mulholland, Ryan Max, Daniel Westreich
69 [GO] 2022―Okt―07 The Impact of COVID-19 on the All of Us Research Program Sarra L Hedden, James McClain, Allison Mandich, Rubin Baskir, Mark S Caulder, Joshua C Denny, et al. (+8)
70 [GO] 2022―Okt―05 CORRECTION TO: IMPACT OF BNT162B2 VACCINATION AND ISOLATION ON SARS-COV-2 TRANSMISSION IN ISRAELI HOUSEHOLDS: AN OBSERVATIONAL STUDY
71 [GO] 2022―Sep―29 Racial Disparities in Pulse Oximeter Device Inaccuracy and Estimated Clinical Impact on COVID-19 Treatment Course Sylvia E K Sudat, Paul Wesson, Kim F Rhoads, Stephanie Brown, Noha Aboelata, Alice R Pressman, et al. (+2)
72 [GO] 2022―Sep―06 Estimating the Effectiveness of First Dose of COVID-19 Vaccine Against Mortality in England: A Quasi-Experimental Study Charlotte Bermingham, Jasper Morgan, Daniel Ayoubkhani, Myer Glickman, Nazrul Islam, Aziz Sheikh, et al. (+3)
73 [GO] 2022―Aug―02 Long-Term Fine Particulate Matter Concentrations and SARS-CoV-2 Prevalence: Differential Relationships by Socioeconomic Status Among Pregnant Individuals in New York City Joan A Casey, Marianthi-Anna Kioumourtzoglou, Elizabeth L Ogburn, Alexander Melamed, Jeffrey Shaman, Sasikiran Kandula, et al. (+4)
74 [GO] 2022―Jul―25 Predicting need for escalation of care or death from repeated daily clinical observations and laboratory results in patients with SARS-CoV-2 Colin J Crooks, Joe West, Andrew Fogarty, Joanne R Morling, Matthew J Grainge, Sherif Gonem, et al. (+7)
75 [GO] 2022―Jun―29 Data-Driven Commentary on SARS-CoV-2 Infection, Vaccination, and Fertility Sigal Klipstein, Jodie A Dionne, Eve C Feinberg, Jennifer F Kawwass, Samantha M Pfeifer, Peter N Schlegel, Catherine Racowsky
76 [GO] 2022―Jun―28 Patterned Outcomes, Unpatterned Counterfactuals, and Spurious Results: Perinatal Health Outcomes Following COVID-19 Alison Gemmill, Joan A Casey, Claire E Margerison, Jennifer Zeitlin, Ralph Catalano, Tim A Bruckner
77 [GO] 2022―Apr―21 Anticipating Racial/Ethnic Mortality Displacement From COVID-19 Stephen M Kissler, Yonatan H Grad
78 [GO] 2022―Mrz―27 Protection of previous SARS-CoV-2 infection is similar to that of BNT162b2 vaccine protection: A three-month nationwide experience from Israel Yair Goldberg, Micha Mandel, Yonatan Woodbridge, Ronen Fluss, Ilya Novikov, Rami Yaari, et al. (+3)
79 [GO] 2022―Mrz―04 Factors associated with SARS-CoV-2 transmission in setting of high COVID-19 vaccination coverage: a case-control study Michael J A Reid, Tommaso C Bulfone, Cinthia Blat, Yea-Hung Chen, George W Rutherford, Susan Philip, et al. (+6)
80 [GO] 2022―Mrz―01 Impact of BNT162b2 vaccination and isolation on SARS-CoV-2 transmission in Israeli households: an observational study Maylis Layan, Mayan Gilboa, Tal Gonen, Miki Goldenfeld, Lilac Meltzer, Alessio Andronico, et al. (+3)
81 [GO] 2022―Feb―14 Factors Associated with Willingness to Receive a COVID-19 Vaccine among 23,819 Adults Aged 50 years and Older: An Analysis of the Canadian Longitudinal Study on Aging Nicole E Basta, Nazmul Sohel, Giorgia Sulis, Christina Wolfson, Geva Maimon, Lauren E Griffith, et al. (+5)
82 [GO] 2022―Jan―25 Identifying and alleviating bias due to differential depletion of susceptible people in post-marketing evaluations of COVID-19 vaccines Rebecca Kahn, Stephanie J Schrag, Jennifer R Verani, Marc Lipsitch
83 [GO] 2022―Jan―24 What has the pandemic revealed about the shortcomings of modern epidemiology? What can we fix or do better? Michelle C Dimitris, Sandro Galea, Julia L Marcus, An Pan, Beate Sander, Robert W Platt
84 [GO] 2022―Jan―12 Effectiveness of Localized Lockdowns in the COVID-19 Pandemic Yige Li, Eduardo A Undurraga, José R Zubizarreta
85 [GO] 2021―Okt―05 Choice of Outcome in COVID-19 Studies and Implications for Policy: Mortality and Fatality Daniel Westreich, Jessie K Edwards, Peter W G Tennant, Eleanor J Murray, Maarten van Smeden
86 [GO] 2021―Sep―29 Explaining ethnic differentials in COVID-19 mortality: cohort study G David Batty, Bamba Gaye, Catharine R Gale, Mark Hamer, Camille Lassale
87 [GO] 2021―Jun―30 Disparities among Racially/Ethnically Marginalized Groups in the COVID-19 Pandemic Persist Regardless of Statewide Shelter-in-Place Policies: An Analysis from Northern California Kristen M J Azar, Stephen H Lockhart, Zijun Shen, Robert Romanelli, Stephanie Brown, Kelly Smits, Alice R Pressman
88 [GO] 2021―Jun―21 Pharmacoepidemiology, Machine Learning and COVID-19: An intent-to-treat analysis of hydroxychloroquine, with or without azithromycin, and COVID-19 outcomes amongst hospitalized US Veterans Hanna Gerlovin, Daniel C Posner, Yuk-Lam Ho, Christopher T Rentsch, Janet P Tate, Joseph T King Jr, et al. (+15)
89 [GO] 2021―Mrz―09 Disparities in COVID-19 deaths by country of birth in Stockholm, Sweden: A total population based cohort study Mikael Rostila, Agneta Cederström, Matthew Wallace, Maria Brandén, Bo Malmberg, Gunnar Andersson
90 [GO] 2021―Mrz―09 Person, Place, Time and COVID-19 Inequities Alina S Schnake-Mahl, Usama Bilal
91 [GO] 2021―Mrz―09 A Geography of Risk: Structural Racism and COVID-19 Mortality in the United States Lauren C Zalla, Chantel L Martin, Jessie K Edwards, Danielle R Gartner, Grace A Noppert
92 [GO] 2021―Feb―10 The Usefulness Of SARS-CoV-2 Test-Positive Proportion As A Surveillance Tool Matt D T Hitchings, Natalie E Dean, Bernardo Garcia-Carreras, Thomas J Hladish, Angkana T Huang, Bingyi Yang, Derek A T Cummings
93 [GO] 2021―Feb―05 The Impact of Epidemiology on Prenatal and Fertility Care during the COVID-19 Pandemic Jodie Dionne-Odom, Sigal Klipstein
94 [GO] 2021―Feb―05 Biases in evaluating the safety and effectiveness of drugs for covid-19: designing real-world evidence studies Christel Renoux, Laurent Azoulay, Samy Suissa
95 [GO] 2020―Dez―21 Teaching Epidemiology Online (Pandemic Edition) Hailey R Banack, Catherine R Lesko, Brian C Whitcomb, Lindsay C Kobayashi
96 [GO] 2020―Jul―23 The Logistics of “Making the Best Use of Test Kits for COVID-19”: Testing More to Test Less P Saha-Chaudhuri
97 [GO] 2020―Jul―18 What Now? Epidemiology in the Wake of a Pandemic Jessie K Edwards, Justin Lessler
98 [GO] 2020―Jun―29 Racial Capitalism within Public Health: How Occupational Settings Drive COVID-19 Disparities Elizabeth S McClure, Pavithra Vasudevan, Zinzi Bailey, Snehal Patel, Whitney R Robinson
99 [GO] 2020―Mai―05 Editorial: Making the Best Use of Test Kits for COVID-19 Clarice R Weinberg
100 [GO] 2020―Jan―08 L2: Cross Border Epidemiology: When Pandemic Influenza Comes to the Northwest, 2004 - 2005 E Sergienko, P Cox, J Hofmann, D Patrick
 [1] 

100 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.003 sec